Table 1.
Variable | N (%) | Range |
---|---|---|
Age [Mean (SD)] | 34.59 (4.82) | 24–42 |
Female | 58 (95.1%) | |
Race/ethnicity | ||
White | 57 (93.4%) | |
Asian | 2 (3.4%) | |
Black/African American | 1 (1.6%) | |
Hispanic/Latino | 1 (1.6%) | |
Education | ||
High school degree | 2 (3.4%) | |
Some college, Trade/Business school | 9 (14.6%) | |
4-year college degree | 25 (41%) | |
Graduate degree | 25 (41%) | |
Employment status | ||
Employed | 44 (72.2%) | |
Student | 3 (4.8%) | |
Medical leave/disability/unemployed | 14 (23.0%) | |
Relationship status | ||
Single, never married | 14 (23.0%) | |
Married/Partnered | 43 (70.4%) | |
Divorced/Widowed | 4 (6.6%) | |
Cancer type | ||
Breast | 44 (72.1%) | |
Othera | 17 (27.9%) | |
Cancer stage | ||
Early Stage (0-III) | 52 (88.1%) | |
Stage IV | 2 (3.4%) | |
Not staged (e.g., brain cancer) | 5 (8.5%) | |
Treatmentb | ||
Surgery | 56 (91.8%) | |
Chemotherapy | 46 (75.4%) | |
Hormone | 37 (60.7%) | |
Radiation | 30 (49.2%) | |
Treatment status | ||
Completed main treatmentc | 54 (88.5%) | |
Months since diagnosis [Mean (SD)] | 28.76 (30.68) | |
Mode of Communication | ||
Face-to-Face | 39 (69.3%) | |
Technology-related: Text | 14 (23.0%) | |
Technology-related: Phone | 8 (13.1%) |
Brain/Hodgkin’s/Cervical/Leukemia/Colon/Ovarian/Thyroid/Salivary gland/Testicular
>1 treatment could be selected
includes hormonal therapy